Status:
ACTIVE_NOT_RECRUITING
Evaluation of the Effectiveness of a Psychoeducational Intervention on Benzodiazepine Use in the Population Over 64 Years Old in Primary Care
Lead Sponsor:
Magi Claveria
Collaborating Sponsors:
Fundacio d'Atencio Primaria
Conditions:
Benzodiazepines Deprescribing
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The objective of this pragmatic, multicenter, randomized controlled clinical trial is to determine whether an educational intervention regarding benzodiazepine use can reduce the consumption and/or do...
Eligibility Criteria
Inclusion
- People over 64 years old who have been using benzodiazepines for a period of three months or more.
- People with an active diagnosis of anxiety and/or insomnia.
Exclusion
- People with psychiatric comorbidities, dementia, epilepsy, included in the home care program (ATDOM), institutionalized, or in palliative care.
- People with no possibility of contact or language barriers.
- People with difficulty traveling to the Primary Care Center (CAP).
Key Trial Info
Start Date :
April 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2025
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT06950567
Start Date
April 1 2024
End Date
May 1 2025
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Primary Care Team of Alfarràs-Almenar.
Almenar, Lleida, Spain, 25126